ISI Order Code:
17OHP 24HR
CPT Code:
83498
Clinical Significance:
17-Hydroxy Progesterone is a steroid derived primarily from enzymatic metabolism of Progesterone and 17-Hydroxy Pregnenolone. It is converted enzymatically to Androstenedione and 11-Deoxycortisol. It is produced in both the gonads and adrenal glands. It is excreted into the urine in conjugated and unconjugated forms of 17-Hydroxy Progesterone and as Pregnanetriol. This assay measures the total of the conjugated and unconjugated forms. It is stimulated by ACTH and suppressed by Dexamethasone. Levels of urine 17-Hydroxy Progesterone are greatly increased in patients with Polycystic Ovarian Disease and Congenital Adrenal Hyperplasia and show exaggerated responses to ACTH in these cases. 17-Hydroxy Progesterone is the marker steroid for determining cases of 21a-Hydroxylase Deficient Congenital Adrenal Hyperplasia. Urine levels are frequently elevated in patients with idiopathic hirsutism
Reference Range:
Urine Adults
Male:
Up to 2.0 µg/24 hrs.
Female:
Up to 4.5 µg/24 hrs.
Pediatric Ranges:
Newborns & Infants:
3 Days to 1 Year: Up to 50 ng/24 hrs.
Children:
1–8 Years: Up to 300 ng/24 hrs.
Procedure:
Urine 17-Hydroxy Progesterone is measured by an immunoassay.
Expected Turnaround Time:
7 Business Days
Report:
Turnaround time is defined as the usual number of days from the date of receipt of a specimen for testing to when the result is released to the ordering facility.
Patient Preparation:
Patient should not be on any Corticosteroid, ACTH, Estrogen, or Gonadotropin medications, if possible, for at least 48 hours prior to collection of specimen.
Specimen Collection:
24 hours urine collection. Refrigerate during collection and mix well. Store specimen refrigerated during collection. No preservatives are required. Transfer 5 – 10 ml urine to urine transport container and freeze immediately. Specimens should be frozen prior to shipping.
Minimum urine specimen size is 1.0 mL
Shipping Instructions:
Ship specimens frozen in dry ice.
References:
1.E Carmina and RA Lobo. Pituitary-Adrenal Responses to Corticotropin-Releasing
Factor in Late Onset 21-Hydroxylase Deficiency. Fertility and Sterility 54: 79-83, 1990.
2.ET Wong, DR Brown, RA Ulstrom, and MW Steffes. Urinary 17-alpha-
Hydroxyprogesterone in Diagnosis and Management of Congenital Adrenal
Hyperplasia. Journal of Clinical Endocrinology and Metabolism 49: 377, 1979.
